Quote
For the respiratory asset package, we have been in contact with over 40 major pharmaceutical and biotechnology companies and funds interested in our programs and small number of discussions are active and well progressed. We remain highly engaged in both the process and ultimate delivery of value to Shareholders.
We therefore continue to work towards executing a sale or licence deal of Invion’s intellectual property.
The Board is grateful for the continued interest and support regularly demonstrated by Shareholders as we engage in this pursuit
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
-0.005(3.85%) |
Mkt cap ! $10.59M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 13.0¢ | 12.0¢ | $16.81K | 134.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 14995 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 12200 | 2 |
View Market Depth
| Last trade - 15.37pm 24/06/2025 (20 minute delay) ? |
| IVX (ASX) Chart |